enGene Therapeutics (ENGN) Exchange Rate Effect (2023 - 2026)
enGene Therapeutics (ENGN) posted Exchange Rate Effect of $1000.0 for Q1 2026, little changed quarter-over-quarter from $1000.0 in Q1 2025, and little changed YoY from $1000.0 in Q1 2025.
Analysis
enGene Therapeutics (ENGN) Exchange Rate Effect (2023 - 2026) Analysis & Trends
enGene Therapeutics (ENGN) has 4 years of Exchange Rate Effect data on file, last reported at $1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Jul 2026 stood at $1000.0 (changed 0.0% YoY), and the FY2025 full-year result was $1000.0, changed 0.0% from the prior year.
- Exchange Rate Effect was $1000.0 for Q1 2026 at enGene Therapeutics, roughly flat from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1000.0 in Q1 2023 to a low of $1000.0 in Q1 2023.
- A 4-year average of $1000.0 and a median of $1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The largest YoY upside for Exchange Rate Effect was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
- enGene Therapeutics' Exchange Rate Effect stood at $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then changed by 0.0% to $1000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $1000.0 in Q1 2026, $1000.0 in Q1 2025, and $1000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.31 Bn | 9.47 Bn | 112.79 Mn | -1.83 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 6,000.00 |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn | -124,000.00 |
| 4 | Legend Biotech | 3.57 Bn | 2.60 Bn | 251.50 Mn | -300,000.00 |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | -774,000.00 |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 1,000.00 |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | - |
| 10 | enGene Therapeutics | 126.92 Mn | 126.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2026 | 1,000.00 |
| Jan 31, 2025 | 1,000.00 |
| Jan 31, 2024 | 1,000.00 |
| Jan 31, 2023 | 1,000.00 |